Optimizing Glycemic Control Through Titration of Insulin Glargine 100 U/mL: A Review of Current and Future Approaches with a Focus on Asian Populations
Chaicharn Deerochanawong
Shailendra Bajpai
I. Made Pande Dwipayana
Zanariah Hussein
Maria Aileen Mabunay
Reynaldo Rosales
Shih-Tzer Tsai
Man Wo Tsang
10.6084/m9.figshare.5904736.v1
https://adisjournals.figshare.com/articles/figure/Optimizing_Glycemic_Control_Through_Titration_of_Insulin_Glargine_100_U_mL_A_Review_of_Current_and_Future_Approaches_with_a_Focus_on_Asian_Populations/5904736
<p><b>Article full text</b></p>
<p><br></p>
<p>The full text of this article can
be found <a href="https://link.springer.com/article/10.1007/s13300-017-0322-z"><b>here</b>.</a></p>
<p><br></p>
<p><b>Provide enhanced content for this
article</b></p>
<p><br></p>
<p>If you are an author of this
publication and would like to provide additional enhanced content for your
article then please contact <a href="http://www.medengine.com/Redeem/âmailto:adisrapidplus@springer.comâ"><b>adisrapidplus@springer.com</b></a>.</p>
<p> </p>
<p>The journal offers a range of
additional features designed to increase visibility and readership. All
features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as ‘peer reviewed’ to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.</p>
<p><br></p>
<p>Other enhanced features include,
but are not limited to:</p>
<p><br></p>
<p>• Slide decks</p>
<p>• Videos and animations</p>
<p>• Audio abstracts</p>
<p>• Audio slides</p>
<p> </p>
<p> </p>
2018-02-20 16:34:54
Asia
Basal insulin
Dose optimization
Dose titration
Insulin glargine 100 U/mL
Type 2 diabetes mellitus